Skip to main content
British Journal of Cancer logoLink to British Journal of Cancer
. 1991 Dec;64(6):1116–1120. doi: 10.1038/bjc.1991.474

Photodynamic therapy with chlorins for diffuse malignant mesothelioma: initial clinical results.

H B Ris 1, H J Altermatt 1, R Inderbitzi 1, R Hess 1, B Nachbur 1, J C Stewart 1, Q Wang 1, C K Lim 1, R Bonnett 1, M C Berenbaum 1, et al.
PMCID: PMC1977841  PMID: 1764375

Abstract

Four patients underwent intraoperative photodynamic therapy after surgery with meso-tetra-(hydroxyphenyl)-chlorin (mTHPC-PDT) for diffuse malignant mesothelioma. Preliminary procedures were performed in two patients in order to establish the efficacy of mTHPC-PDT and to optimise its tumoricidal effect. The tumoricidal effect was related to the mTHPC dose, light dose and the time interval between sensitation and activation. 0.3 mg kg-1 mTHPC activated after 48 h with 10 Joules cm-2 of non-thermal laser light at 650 nm resulted in a 10 mm deep tumour infarction, due to tumour vessel necrosis and thrombosis. The mTHPC tissue concentration was up to 14 times higher in the tumour than in normal tissues. Skin photosensitivity was mild, dose dependent and occurred 3 to 10 days after administration of mTHPC. According to the results obtained, intraoperative mTHPC-PDT was performed following pleuropneumonectomy in two, pleurectomy and lobectomy in one and pleurectomy in one patient. Ten Joules cm-2 were delivered to the diaphragm and the costophrenic sulcus and 5 Joules cm-2 to the remaining thoracic cavity. The postoperative course was marked by loss of appetite, fluid retention, hypoproteinemia and severe chest pain. One patient succumbed from aspiration pneumonia. The remaining patients developed no neural or vascular alterations and no bronchial stump insufficiency during follow-up. mTHPC-PDT following surgical tumour resection deserves further evaluation in good risk patients with diffuse malignant mesothelioma.

Full text

PDF
1116

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Faber L. P. Surgical treatment of asbestos-related disease of the chest. Surg Clin North Am. 1988 Jun;68(3):525–543. doi: 10.1016/s0039-6109(16)44532-9. [DOI] [PubMed] [Google Scholar]
  2. Feins R. H., Hilf R., Ross H., Gibson S. L. Photodynamic therapy for human malignant mesothelioma in the nude mouse. J Surg Res. 1990 Oct;49(4):311–314. doi: 10.1016/0022-4804(90)90027-y. [DOI] [PubMed] [Google Scholar]
  3. Herrera-Ornelas L., Petrelli N. J., Mittelman A., Dougherty T. J., Boyle D. G. Photodynamic therapy in patients with colorectal cancer. Cancer. 1986 Feb 1;57(3):677–684. doi: 10.1002/1097-0142(19860201)57:3<677::aid-cncr2820570347>3.0.co;2-v. [DOI] [PubMed] [Google Scholar]
  4. Lerner H. J., Schoenfeld D. A., Martin A., Falkson G., Borden E. Malignant mesothelioma. The Eastern Cooperative Oncology Group (ECOG) experience. Cancer. 1983 Dec 1;52(11):1981–1985. doi: 10.1002/1097-0142(19831201)52:11<1981::aid-cncr2820521102>3.0.co;2-p. [DOI] [PubMed] [Google Scholar]
  5. Lofgren L., Larsson M., Thaning L., Hallgren S. Transthoracic endoscopic photodynamic treatment of malignant mesothelioma. Lancet. 1991 Feb 9;337(8737):359–359. doi: 10.1016/0140-6736(91)90983-v. [DOI] [PubMed] [Google Scholar]
  6. Moan J., Peng Q., Evensen J. F., Berg K., Western A., Rimington C. Photosensitizing efficiencies, tumor- and cellular uptake of different photosensitizing drugs relevant for photodynamic therapy of cancer. Photochem Photobiol. 1987 Nov;46(5):713–721. doi: 10.1111/j.1751-1097.1987.tb04837.x. [DOI] [PubMed] [Google Scholar]
  7. Nambisan R. N., Karakousis C. P., Holyoke E. D., Dougherty T. J. Intraoperative photodynamic therapy for retroperitoneal sarcomas. Cancer. 1988 Mar 15;61(6):1248–1252. doi: 10.1002/1097-0142(19880315)61:6<1248::aid-cncr2820610632>3.0.co;2-5. [DOI] [PubMed] [Google Scholar]
  8. Pandey R. K., Bellnier D. A., Smith K. M., Dougherty T. J. Chlorin and porphyrin derivatives as potential photosensitizers in photodynamic therapy. Photochem Photobiol. 1991 Jan;53(1):65–72. doi: 10.1111/j.1751-1097.1991.tb08468.x. [DOI] [PubMed] [Google Scholar]
  9. Pass H. I., Tochner Z., DeLaney T., Smith P., Friauf W., Glatstein E., Travis W. Intraoperative photodynamic therapy for malignant mesothelioma. Ann Thorac Surg. 1990 Oct;50(4):687–688. doi: 10.1016/0003-4975(90)90230-4. [DOI] [PubMed] [Google Scholar]
  10. Sindelar W. F., DeLaney T. F., Tochner Z., Thomas G. F., Dachoswki L. J., Smith P. D., Friauf W. S., Cole J. W., Glatstein E. Technique of photodynamic therapy for disseminated intraperitoneal malignant neoplasms. Phase I study. Arch Surg. 1991 Mar;126(3):318–324. doi: 10.1001/archsurg.1991.01410270062011. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES